{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:54:00Z","timestamp":1790747640846,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T00:00:00Z","timestamp":1421020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jsps.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T07:31:38Z","timestamp":1421047898000},"page":"494-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Hyperphosphatemia Management in Patients with Chronic Kidney Disease"],"prefix":"10.1007","volume":"24","author":[{"given":"Ahmed M.","family":"Shaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2015.01.009_b0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14656566.6.2.319","article-title":"Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients","volume":"6","author":"Albaaj","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jsps.2015.01.009_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI100224","article-title":"Studies on the physiology of the parathyroid glands: I. calcium and phosphorus studies on a case of idiopathic hypoparathyroidism","volume":"7","author":"Albright","year":"1929","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.mcg.0000196408.60851.cf","article-title":"Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function","volume":"40","author":"Aydogan","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jsps.2015.01.009_b0025","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2005040392","article-title":"Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study","volume":"16","author":"Ayus","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0030","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1359\/jbmr.060714","article-title":"Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast","volume":"21","author":"Baldock","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsps.2015.01.009_b0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1752-1947-8-74","article-title":"Iatrogenic hypervitaminosis D as an unusual cause of persistent vomiting: a case report","volume":"8","author":"Bansal","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jsps.2015.01.009_b0040","first-page":"103","article-title":"The role of metabolic acidosis in causing uremic hyperphosphatemia","volume":"12","author":"Barsotti","year":"1986","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.jsps.2015.01.009_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00580003","article-title":"Renal phosphate transport: inhomogeneity of local proximal transport rates and sodium dependence","volume":"356","author":"Baumann","year":"1975","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jsps.2015.01.009_b0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1542-4758.2006.00100.x","article-title":"Phosphate binders: new products and challenges","volume":"10","author":"Bellasi","year":"2006","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5301\/JN.2011.8446","article-title":"Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients","volume":"25","author":"Bellasi","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.jsps.2015.01.009_b0060","first-page":"F927","article-title":"Proximal tubule site of inhibition of phosphate reabsorption by calcitonin","volume":"246","author":"Berndt","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","article-title":"Phosphatonins and the regulation of phosphate homeostasis","volume":"69","author":"Berndt","year":"2007","journal-title":"Ann. Rev. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0070","first-page":"1170","article-title":"\u201cPhosphatonins\u201d and the regualtion of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0075","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.0704446104","article-title":"Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption","volume":"104","author":"Berndt","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsps.2015.01.009_b0080","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJM197211022871801","article-title":"Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man","volume":"287","author":"Brickman","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0090","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia","volume":"330","author":"Cai","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/endo-127-1-453","article-title":"Stimulatory effect of insulin-like growth factor-1 on renal Pi transport and plasma 1,25-dihydroxyvitamin D3","volume":"127","author":"Caverzasio","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsps.2015.01.009_b0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(73)92536-1","article-title":"1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure","volume":"2","author":"Chalmers","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2015.01.009_b0105","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/14.12.2907","article-title":"Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients","volume":"14","author":"Chertow","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0115","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in haemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0120","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0125","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0130","first-page":"29","article-title":"Phosphate control in chronic uremia: don\u2019t forget diet","volume":"16","author":"Cupisti","year":"2003","journal-title":"J. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/0886022X.2011.552821","article-title":"Pharmacology of the phosphate binder, lanthanum carbonate","volume":"33","author":"Damment","year":"2011","journal-title":"Ren. Fail."},{"key":"10.1016\/j.jsps.2015.01.009_b0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00658486","article-title":"Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1,25-dihydroxycholecalciferol","volume":"388","author":"Danisi","year":"1980","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jsps.2015.01.009_b0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/00365521.1990.12067093","article-title":"Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3","volume":"25","author":"Danisi","year":"1990","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jsps.2015.01.009_b0150","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1046\/j.1523-1755.1999.00419.x","article-title":"Gamma-l-glutamyl-l-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate","volume":"55","author":"de Toledo","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1681\/ASN.V3196","article-title":"Calcium acetate as a phosphorus binder in hemodialysis patients","volume":"3","author":"Delmez","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0160","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1681\/ASN.V451214","article-title":"Phosphate kinetics during high-flux hemodialysis","volume":"4","author":"Desoi","year":"1993","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0165","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients","author":"D\u2019Haese","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.jsps.2015.01.009_b0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjhf\/hfq106","article-title":"Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community","volume":"12","author":"Dhingra","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jsps.2015.01.009_b0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/bj1820429","article-title":"Effect of vitamin D deficiency on bone formation in the chick","volume":"182","author":"Dickson","year":"1979","journal-title":"Biochem. J."},{"issue":"Suppl 1","key":"10.1016\/j.jsps.2015.01.009_b0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-6686.2009.00051.x","article-title":"The use of phosphate binders: data from contributors to the European Practice Database","volume":"35","author":"Elseviers","year":"2009","journal-title":"J. Ren. Care"},{"key":"10.1016\/j.jsps.2015.01.009_b0185","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.239.23.2472","article-title":"Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia","volume":"239","author":"Ettinger","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.jsps.2015.01.009_b0190","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","article-title":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","volume":"149","author":"Ferramosca","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jsps.2015.01.009_b0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1185\/030079905X41453","article-title":"A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis","volume":"21","author":"Finn","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jsps.2015.01.009_b0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ki.1995.22","article-title":"Clinical and echocardiographic disease in patients starting end-stage renal disease therapy","volume":"47","author":"Foley","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0205","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02233563","article-title":"Ionic constituents and osmolality of gastric and small-intestinal fluids after eating","volume":"11","author":"Fordtran","year":"1966","journal-title":"Am. J. Dig. Dis."},{"key":"10.1016\/j.jsps.2015.01.009_b0210","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1073\/pnas.79.16.4932","article-title":"Glucocorticoids increase the Na+\u2013H+ exchange and decrease the Na+ gradient-dependent phosphate-uptake systems in renal brush border membrane vesicles","volume":"79","author":"Freiberg","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsps.2015.01.009_b0215","first-page":"F674","article-title":"Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group","volume":"244","author":"Friedlaender","year":"1983","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0220","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0225","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.69.7.1673","article-title":"Control of 25-hydroxycholecalciferol metabolism by parathyroid glands","volume":"69","author":"Garabedian","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsps.2015.01.009_b0230","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jsps.2015.01.009_b0235","doi-asserted-by":"crossref","first-page":"12919","DOI":"10.1074\/jbc.270.21.12919","article-title":"Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs","volume":"270","author":"Garrett","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsps.2015.01.009_b0240","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1042\/bj0282092","article-title":"On the action of parathormone","volume":"28","author":"Goadby","year":"1934","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"Pt 2","key":"10.1016\/j.jsps.2015.01.009_b0250","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/bj3200615","article-title":"Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney","volume":"320","author":"Hafdi","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0255","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1042\/bj0311705","article-title":"The circulation of phosphorus in the body revealed by application of radioactive phosphorus as indicator","volume":"31","author":"Hahn","year":"1937","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0260","first-page":"287","article-title":"Chronic gastrointestinal symptoms in hemodialysis patients","volume":"110","author":"Hammer","year":"1998","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.jsps.2015.01.009_b0265","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0005-2736(80)90378-8","article-title":"Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone","volume":"603","author":"Hammerman","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsps.2015.01.009_b0270","first-page":"E616","article-title":"Insulin stimulates Pi transport in brush border vesicles from proximal tubular segments","volume":"247","author":"Hammerman","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0275","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1042\/bj0190882","article-title":"Normal variations of the inorganic phosphate of blood","volume":"19","author":"Havard","year":"1925","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jsps.2015.01.009_b0290","first-page":"365","article-title":"Metabolic bone disease in chronic renal failure. I. Dialyzed uremics","volume":"78","author":"Huffer","year":"1975","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsps.2015.01.009_b0295","first-page":"385","article-title":"Metabolic bone disease in chronic renal failure. II. Renal transplant patients","volume":"78","author":"Huffer","year":"1975","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsps.2015.01.009_b0300","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfh282","article-title":"Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate","volume":"19","author":"Hutchison","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0305","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000084653","article-title":"Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate","volume":"100","author":"Hutchison","year":"2005","journal-title":"Nephron. Clin. Pract."},{"key":"10.1016\/j.jsps.2015.01.009_b0310","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrneph.2011.112","article-title":"Pharmacology, efficacy and safety of oral phosphate binders","volume":"7","author":"Hutchison","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0315","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20041799","article-title":"Role of the vitamin D receptor in FGF23 action on phosphate metabolism","volume":"390","author":"Inoue","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20090671","article-title":"Thyroid hormones regulate phosphate homoeostasis through transcriptional control of the renal type IIa sodium-dependent phosphate co-transporter (Npt2a) gene","volume":"427","author":"Ishiguro","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0325","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study","volume":"25","author":"Ix","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bj2520105","article-title":"Study of the mechanism by which the Na+-Pi co-transporter of mouse kidney proximal-tubule cells adjusts to phosphate depletion","volume":"252","author":"Jahan","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0335","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0272-6386(00)70003-5","article-title":"Calcified subcutaneous arterioles with infarcts of the subcutis and skin (\u201ccalciphylaxis\u201d) in chronic renal failure","volume":"35","author":"Janigan","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsps.2015.01.009_b0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","article-title":"Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia","volume":"42","author":"Joy","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"Pt 3","key":"10.1016\/j.jsps.2015.01.009_b0345","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj3430705","article-title":"Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3","volume":"343","author":"Katai","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0350","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bj0200791","article-title":"Kidney phosphatase","volume":"20","author":"Kay","year":"1926","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0005-2736(85)90477-8","article-title":"Effects of fasting compared to low phosphorus diet on the kinetics of phosphate transport by renal brush-border membranes","volume":"815","author":"Kempson","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsps.2015.01.009_b0360","unstructured":"Kidney Disease: Improving Global Outcomes, C.K.D.M.B.D.W.G., 2009. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., S1\u2013130."},{"key":"10.1016\/j.jsps.2015.01.009_b0365","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1046\/j.1523-1755.1999.07163.x","article-title":"Factors associated with calcification of the abdominal aorta in hemodialysis patients","volume":"71","author":"Kimura","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.jsps.2015.01.009_b0370","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000096410","article-title":"Practical approaches to management of hyperphosphatemia: can we improve the current situation?","volume":"25","author":"Kuhlmann","year":"2007","journal-title":"Blood Purif."},{"key":"10.1016\/j.jsps.2015.01.009_b0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0005-2736(85)90066-5","article-title":"Mechanism of stimulation of renal phosphate transport by 1,25-dihydroxycholecalciferol","volume":"817","author":"Kurnik","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsps.2015.01.009_b0380","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00041552-200109000-00003","article-title":"Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients","volume":"10","author":"Levin","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jsps.2015.01.009_b0385","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0390","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-2952(89)90043-9","article-title":"Inhibition by volume expansion of phosphate uptake by the renal proximal tubule brush border membrane","volume":"38","author":"Liput","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsps.2015.01.009_b0395","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2009.136895","article-title":"Hyperphosphatemia in a 56-year-old man with hypochondrial pain","volume":"56","author":"Loh","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsps.2015.01.009_b0400","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0405","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3748\/wjg.14.2615","article-title":"Lower gastrointestinal bleeding: association with Sevelamer use","volume":"14","author":"Madan","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jsps.2015.01.009_b0410","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0415","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0420","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1152\/ajpendo.00065.2005","article-title":"Acute regulation of parathyroid hormone by dietary phosphate","volume":"289","author":"Martin","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jsps.2015.01.009_b0425","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/BJ20100484","article-title":"Regulation of renal sodium-dependent phosphate co-transporter genes (Npt2a and Npt2c) by all-trans-retinoic acid and its receptors","volume":"429","author":"Masuda","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0430","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","article-title":"Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use","volume":"57","author":"Maton","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jsps.2015.01.009_b0435","doi-asserted-by":"crossref","first-page":"e74996","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsps.2015.01.009_b0440","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1042\/bj0270934","article-title":"Some considerations regarding and investigations into calcium and phosphorus metabolism","volume":"27","author":"McGowan","year":"1933","journal-title":"Biochem. J."},{"issue":"Pt 1","key":"10.1016\/j.jsps.2015.01.009_b0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bj3050081","article-title":"Cloning and functional expression of a Na(+)-dependent phosphate co-transporter from human kidney: cDNA cloning and functional expression","volume":"305","author":"Miyamoto","year":"1995","journal-title":"Biochem. J."},{"issue":"Pt 3","key":"10.1016\/j.jsps.2015.01.009_b0450","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1042\/bj3270735","article-title":"Relative contributions of Na+-dependent phosphate co-transporters to phosphate transport in mouse kidney: RNase H-mediated hybrid depletion analysis","volume":"327","author":"Miyamoto","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0455","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0460","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl 3","key":"10.1016\/j.jsps.2015.01.009_b0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0475","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1172\/JCI104888","article-title":"Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate in man","volume":"43","author":"Mostellar","year":"1964","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0480","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","article-title":"Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis","volume":"53","author":"Mucsi","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0485","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation 2000. Clinical practice guidelines for nutrition in chronic renal failure. K\/DOQI, National Kidney Foundation. Am. J. Kidney Dis., 35, S1\u2013140.","DOI":"10.1016\/S0272-6386(00)70225-3"},{"key":"10.1016\/j.jsps.2015.01.009_b0490","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation, 2003. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis., 42, S1\u2013201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"10.1016\/j.jsps.2015.01.009_b0495","first-page":"CD006023","article-title":"Phosphate binders for preventing and treating bone disease in chronic kidney disease patients","author":"Navaneethan","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jsps.2015.01.009_b0500","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/BJ20101708","article-title":"Role of mitochondrial phosphate carrier in metabolism-secretion coupling in rat insulinoma cell line INS-1","volume":"435","author":"Nishi","year":"2011","journal-title":"Biochem. J."},{"issue":"Pt 2","key":"10.1016\/j.jsps.2015.01.009_b0505","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj2930377","article-title":"Parathyroid hormone transport effects and hormonal processing in primary cultured rat proximal tubular cells","volume":"293","author":"O\u2019Donovan","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0510","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0515","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/bj0330663","article-title":"The absorption of phosphates from the intestine","volume":"33","author":"Patwardhan","year":"1939","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0525","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2036.2004.02178.x","article-title":"Effects of effervescent ranitidine on gastric pH: comparison with almagate and placebo in fasting and postprandial conditions","volume":"20","author":"Rey","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2015.01.009_b0530","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism","volume":"13","author":"Ribeiro","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0535","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.92.1.131","article-title":"Cloning and functional expression of a rat kidney extracellular calcium\/polyvalent cation-sensing receptor","volume":"92","author":"Riccardi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsps.2015.01.009_b0540","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.1984.00350140077012","article-title":"Prevention of acute renal failure in traumatic rhabdomyolysis","volume":"144","author":"Ron","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0550","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0555","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000187515","article-title":"Oral calcium effectively reduces parathyroid hormone levels in hemodialysis patients: a randomized double-blind placebo-controlled study","volume":"65","author":"Rudnicki","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.jsps.2015.01.009_b0560","first-page":"1366","article-title":"Unsatisfactory control of serum phosphate: why is it so common and what can be done?","volume":"9","author":"Schaefer","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0565","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study","volume":"83","author":"Sheikh","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0570","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsps.2015.01.009_b0575","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0580","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1172\/JCI105382","article-title":"The control of phosphate excretion in uremia","volume":"45","author":"Slatopolsky","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0585","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI105877","article-title":"Control of phosphate excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0595","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardivascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study","volume":"16","author":"Slinin","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0600","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/bj1960187","article-title":"Regulation of vitamin D metabolism by calcium and phosphate ions in isolated renal tubules","volume":"196","author":"Spanos","year":"1981","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0605","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsps.2015.01.009_b0610","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0615","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj1800465","article-title":"Effect of dietary phosphate intake on phosphate transport by isolated rat renal brush-border vesicles","volume":"180","author":"Stoll","year":"1979","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0620","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/ndt\/17.8.1434","article-title":"The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being","volume":"17","author":"Strid","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0625","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ndt\/18.3.570","article-title":"Overuse of acid suppressant drugs in patients with chronic renal failure","volume":"18","author":"Strid","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jsps.2015.01.009_b0630","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI106155","article-title":"Effect of expansion of extracellular fluid volume on renal phosphate handling","volume":"48","author":"Suki","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsps.2015.01.009_b0635","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/bj1340913","article-title":"Binding of parathyroid hormone to bovine kidney-cortex plasma membranes","volume":"134","author":"Sutcliffe","year":"1973","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0640","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10157-005-0363-x","article-title":"Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients","volume":"9","author":"Tamura","year":"2005","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jsps.2015.01.009_b0645","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortlaity risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The dialysis outcomes and practice patterns study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jsps.2015.01.009_b0650","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jsps.2015.01.009_b0655","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsps.2015.01.009_b0660","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1525-139X.2007.00309.x","article-title":"Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake","volume":"20","author":"Uribarri","year":"2007","journal-title":"Semin. Dial."},{"key":"10.1016\/j.jsps.2015.01.009_b0665","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/endo.136.8.7628353","article-title":"Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo","volume":"136","author":"Uy","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsps.2015.01.009_b0670","first-page":"45","article-title":"Detection and pathogenesis of visceral calcification in dialysis patients and patients with malignant disease","volume":"118","author":"Velentzas","year":"1978","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0675","first-page":"49","article-title":"Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload","volume":"131","author":"von Bonsdorff","year":"1990","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"10.1016\/j.jsps.2015.01.009_b0680","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj0620593","article-title":"Studies on the skeletal tissues. 4. The renewal of inorganic phosphate in bones of various species of small mammal as a function of time","volume":"62","author":"Weidmann","year":"1956","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0685","doi-asserted-by":"crossref","first-page":"R301","DOI":"10.1152\/ajpregu.2001.280.2.R301","article-title":"Evolution of the Na-P(i) cotransport systems","volume":"280","author":"Werner","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jsps.2015.01.009_b0690","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2369-14-178","article-title":"Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005\u20132010","volume":"14","author":"Wojcicki","year":"2013","journal-title":"BMC Nephrol."},{"issue":"Pt 1","key":"10.1016\/j.jsps.2015.01.009_b0695","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/bj3520227","article-title":"Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production","volume":"352","author":"Xie","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsps.2015.01.009_b0700","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am. J. Kidney Dis."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016415000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016415000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:10Z","timestamp":1736184550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016415000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":140,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1319016415000109"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2015.01.009","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphatemia Management in Patients with Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}